
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging is showing early signs of traction in its top-line growth and continues to focus on expanding its U.S. distribution activity for its Nanox.ARC segment. However, they faced a non-cash impairment in the fourth quarter of 2025 due to a restructuring of their Korean manufacturing footprint. The company also has several risk factors that include regulatory and market share risk, but they recently signed a partnership agreement with Digital X-Ray Imaging, which should help drive adoption in underserved settings and support a scalable U.S. rollout. The partnership leverages Digital X-Ray Imaging's established procurement relationships and infrastructure, giving Nano X a key advantage in penetrating hospital networks and outpatient settings for their integrated medical imaging and healthcare services platform.
Bears say
Nano X Imaging is facing significant challenges, including regulatory risks, financial risks related to partnerships, commercial risks related to market adoption, legal and intellectual property risks, and competition for market share. Despite their progress in signing distribution agreements, significant revenue momentum is still years away, and the success of their strategy will depend on key metrics such as system placements, utilization rates, and reimbursement dynamics. Based on these challenges and uncertainties, the financial outlook for Nano X Imaging is negative.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares